Despite the coronavirus pandemic, the U.S. Food and Drug Administration can resume enforcing a one-of-a-kind requirement that women visit clinics to obtain abortion-inducing medication, the U.S. Supreme Court's conservatives ruled Tuesday night.
The U.S. Supreme Court on Thursday declined a request to immediately revive restrictions on the abortion drug mifepristone during the pandemic, sending the case back to the district court over objections from Justices Clarence Thomas and Samuel A. Alito that the court is treating abortion cases differently from religious liberty cases.
Nearly two dozen Democratic attorneys general asked the U.S. Supreme Court on Tuesday to stay out of a fight over the U.S. Food and Drug Administration's limits on abortion medication access, saying the agency's rules threaten public health during the coronavirus pandemic.
Nearly a dozen states are throwing their support behind the U.S. Food and Drug Administration's attempt to convince the U.S. Supreme Court to hit pause on an injunction that requires the agency to increase access to the so-called abortion pill.
The U.S. Food and Drug Administration asked the U.S. Supreme Court on Wednesday to reinstate its rules requiring people to go to a medical facility to get the abortion drug Mifeprex or its generic equivalent, fighting a district court judge who lifted those restrictions nationwide because of the pandemic.